CANSINOBIO

6185
23.3401.85% ( -0.440 )
Delay Closed: Nov 16, 16:08:11

Financials

Q3 FY2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: CANSINOBIO(06185) the Revenue is 389 M (+14.71%), Miss estimate;the EBIT is 99.78 M (+224.3%), Beat estimate;the EPS is 0.0819 (-31.88%), Miss estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.39B14.71%
0.47B37.76%
-0.08B23.05%
EBITExceed expectations
0.10B224.31%
0.07B136.94%
+0.03B87.37%
EPSMiss expectations
0.081931.88%
0.2946145.02%
-0.2127176.90%

Upcoming earnings report - FY2026 Annual Earning Release

Available dateMar 5, 2027
Estimate Revenue1.674 B
Estimate EBIT--
Estimate EPS0.5021

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly